Skip to content

Who we are

Advancing cancer care through data-driven innovation

Our goal is to enable earlier diagnoses, evidence-based interventions and equitable access to care, through digital tools designed for low-resource settings.

Our story

Addressing late detection with smart, scalable solutions

The ANORA Cancer Registry began in response to the high number of breast cancers diagnosed at a late stage in Cameroon. Launched in 2023, it now records every cancer that participating facilities report: a centralised data system that supports early detection, follows each patient's care and informs clinical decisions. Built for accuracy, privacy and interoperability, it works alongside IntelliBra's AI-assisted breast screening points, patient apps and clinician tools.

Our impact

A connected infrastructure for sustainable health impact

The registry is a real-time health data repository that serves individual care and population-level insight alike. By streamlining data capture and following each patient over time, it closes gaps in care, shortens the time to diagnosis and supports research on local patterns of disease.

Why cancer data matters

Transforming cancer control through evidence

The registry turns raw screening data into intelligence for:

  • Early detection

    Spotting patterns sooner through trend analysis over time.

  • Public health action

    Supporting data-informed outreach and screening campaigns.

  • Advancing research

    Supplying high-quality, de-identified data for clinical and AI research.

  • Health equity

    Identifying and addressing regional differences in access to care.

Our data journey

From screening to scientific insight, centred on you

The registry follows each record through a secure lifecycle, from patient registration to a validated diagnosis, with integrity and transparency at its core.

Analysis and result generation

Pathology, imaging and, at IntelliBra screening points, AI results are brought together; a specialist validates them with clinical annotations to settle the diagnosis and the follow-up.

Join us in reinventing cancer care infrastructure

Collaborate with us to scale equitable screening, generate meaningful public health data and enable precise care pathways in resource-constrained settings.